Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 29 min ago
Peer-reviewedCC BY-NC 4.0The European Journal of Public Health

Personalised HeartCare Trial: Preliminary Results on Genomic Literacy and PRS Psychological Impact

Abstract

Background: Primary prevention of cardiovascular diseases (CVD) represents a priority given the growing disease burden. Polygenic risk scores (PRS) may have the potential of improving behaviors especially among individuals at high PRS-risk. The Personalised HeartCare (PHC) trial aims to assess the effect of PRS disclosure on lifestyle behaviors.

Methods: PHC is a single-arm monocentric trial conducted at Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, enrolling healthy ≥40 years adults with low 10-year CVD risk (ClinicalTrials.gov NCT06888466). Primary endpoint is change in CardioVascular Health (CVH) assessed by Life’s Essential 8 (LE8, 0-100) at 12 months. At baseline, PRS testing was performed and genomic literacy was assessed using Vanderbilt PRS-Knowledge Scale (PRS‑KS:0 to 7, with 0-2=low). One month after PRS disclosure(T1), psychological responses were measured with FACToR questionnaire (negativity, uncertainty, privacy 0-12; positivity 0-16).Recruitment is finalized while follow-up is still ongoing.

Results: 434 participants were enrolled (60% female, mean age 56±7.2). Mean LE8 score was 65.5±10.6, with 83% classified as intermediate CVH. Among 432 genotyped participants, 56 (13%) had high PRS and 376 (87%) non-high. Genomic literacy, assessed in 406 participants, showed mean PRS‑KS score of 4.6 ± 1.5, with no differences between PRS groups. At T1, mean FACToR scores across all participants were: negativity 1.3±1.8, uncertainty 2.0±2.2, privacy 1.0±1.5, positivity 9.6±3.4. High PRS recipients showed significantly greater negativity and uncertainty, and lower positivity compared with non-high PRS (all p < 0.001).

Conclusions: Baseline findings from the PHC trial describe a population with intermediate CVH and good Genomic literacy. Preliminary results show that high PRS disclosure is associated with emotional distress and uncertainty. Ongoing follow-up will clarify whether PRS disclosure influences lifestyle change.

Thanks to DARE-CUP:B53C22006320001

Key messages: • High PRS disclosure for CVD is associated with significantly greater negativity and uncertainty in a pilot study in Italy, highlighting the need for tailored communication strategies.

• Most participants had intermediate cardiovascular health at baseline, suggesting room for lifestyle improvement through PRS-based personalized prevention.

Related

  1. A pilot study of invasive vagus nerve stimulation in Chinese patients with Alzheimer’s disease: preliminary results on safety, cognition, and biomarkers
    Yingchuan Chen, Tenghong Lian, Dongmei Luo +10
    Frontiers in neurosciencePeer-reviewedCC BYFull textNeuroscienceEurope PMC
  2. Babesia divergens experimental infection of spleen-intact sheep results in long-lasting parasitemia despite a strong humoral response: Preliminary results
    Emmanuelle Moreau, Maggy Jouglin, Alain Chauvin +1
    Veterinary ParasitologyPeer-reviewedCC BY-NC 4.0Full text12 citedZoology & animal behaviourHAL
  3. Tracking ageing over three decades: preliminary results from the EPIC-Turin Recall Study
    L Milani, I Giommarini, A Bianchi +7
    The European Journal of Public HealthPeer-reviewedCC BY-NC 4.0Full textCell biologyPMCEurope PMC
  4. SOFTPEERS: feasibility, acceptability, and preliminary effectiveness of a peer-led intervention to prevent binge drinking in adolescents. Results from a mixed-methods pilot cluster-randomized controlled trial
    Florence Cousson-Gélie, Olivier Lareyre, Emilie Charton +10
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textGeneral biologyEpidemiology & public healthHALHAL
  5. Personalised prediction of anomalous bone regeneration in multiple myeloma patients
    F. Gibson, R. E. Andrews, M. A. Lawson +10
    bioRxivPreprintCC BYFull textSystems & synthetic biologybioRxiv
BibTeX
@article{proto2026personalised,
  title = {{Personalised HeartCare Trial: Preliminary Results on Genomic Literacy and PRS Psychological Impact}},
  author = {L Proto and L Russo and R Galarducci and E Pascucci and G Antonini and G Liuzzo and T Pasciuto and R Amore and R Pastorino and S Boccia},
  journal = {The European Journal of Public Health},
  year = {2026},
  month = oct,
  doi = {10.1093/eurpub/ckag169.1103},
  url = {https://doi.org/10.1093/eurpub/ckag169.1103},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Personalised HeartCare Trial: Preliminary Results on Genomic Literacy and PRS Psychological Impact
AU  - L Proto
AU  - L Russo
AU  - R Galarducci
AU  - E Pascucci
AU  - G Antonini
AU  - G Liuzzo
AU  - T Pasciuto
AU  - R Amore
AU  - R Pastorino
AU  - S Boccia
PY  - 2026
DA  - 2026/10/01
JO  - The European Journal of Public Health
DO  - 10.1093/eurpub/ckag169.1103
UR  - https://doi.org/10.1093/eurpub/ckag169.1103
AB  - Background: Primary prevention of cardiovascular diseases (CVD) represents a priority given the growing disease burden. Polygenic risk scores (PRS) may have the potential of improving behaviors especially among individuals at high PRS-risk. The Personalised HeartCare (PHC) trial aims to assess the effect of PRS disclosure on lifestyle behaviors.  Methods: PHC is a single-arm monocentric trial conducted at Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, enrolling healthy ≥40 years adults with low 10-year CVD risk (ClinicalTrials.gov NCT06888466). Primary endpoint is change in CardioVascular Health (CVH) assessed by Life’s Essential 8 (LE8, 0-100) at 12 months. At baseline, PRS testing was performed and genomic literacy was assessed using Vanderbilt PRS-Knowledge Scale (PRS‑KS:0 to 7, with 0-2=low). One month after PRS disclosure(T1), psychological responses were measured with FACToR questionnaire (negativity, uncertainty, privacy 0-12; positivity 0-16).Recruitment is finalized while follow-up is still ongoing.  Results: 434 participants were enrolled (60% female, mean age 56±7.2). Mean LE8 score was 65.5±10.6, with 83% classified as intermediate CVH. Among 432 genotyped participants, 56 (13%) had high PRS and 376 (87%) non-high. Genomic literacy, assessed in 406 participants, showed mean PRS‑KS score of 4.6 ± 1.5, with no differences between PRS groups. At T1, mean FACToR scores across all participants were: negativity 1.3±1.8, uncertainty 2.0±2.2, privacy 1.0±1.5, positivity 9.6±3.4. High PRS recipients showed significantly greater negativity and uncertainty, and lower positivity compared with non-high PRS (all p < 0.001).  Conclusions: Baseline findings from the PHC trial describe a population with intermediate CVH and good Genomic literacy. Preliminary results show that high PRS disclosure is associated with emotional distress and uncertainty. Ongoing follow-up will clarify whether PRS disclosure influences lifestyle change.  Thanks to DARE-CUP:B53C22006320001  Key messages: • High PRS disclosure for CVD is associated with significantly greater negativity and uncertainty in a pilot study in Italy, highlighting the need for tailored communication strategies.  • Most participants had intermediate cardiovascular health at baseline, suggesting room for lifestyle improvement through PRS-based personalized prevention.
SN  - 1101-1262
SN  - 1464-360X
ER  -